Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Managed IT Services As A Money Saving Mechanism

Successful business owners realize the importance of reducing operating costs without affecting their company’s overall performance. Saving time and money is always a fundamental business goal, and it is more important than ever in small and midsize companies...
Lloyd Ainey | September 2, 2020 |

Gold and the Debasement of Currency Con

It is reasonably well known that many Roman emperors debased their currency (coinage). This was a very bad practice, since it is really a reflection of the debasement of the value of the kingdom (empire or country); going from a honest and just society to a corrupt and unjust ...
Hubert Moolman | April 29, 2020 |

Market Action Suggests Downside in Precious Metals

At present, there could be a number of positive developments for precious metals. Last Friday, the US Dollar cracked lower and could be at risk of lower levels into year end. Days earlier the Federal Reserve announced new “QE-like” measures just a...
Jordan Roy-Byrne, CMT | October 15, 2019 |

Karuna Shares Jump 375% Higher on Phase 2 Acute Psychosis Treatment Trial Data

Shares of Karuna Therapeutics, which completed an IPO in July 2019, soared more than 375% higher today after the firm reported that its KarXT met primary endpoint in a phase 2 clinical trial of acute psychosis in patients with schizophrenia. This morning clinical-stag...
Streetwise Reports | November 19, 2019 |

Insmed Shares Trade 40% Higher on Phase 2 Top-Line Bronchiectasis Trial Data

Insmed Inc.'s shares traded higher today after the company reported positive top-line results from its Phase 2 WILLOW Study of INS1007 in patients with non-cystic fibrosis bronchiectasis. Global biopharmaceutical company Insmed Inc. (INSM:NASDAQ) , which is...
Streetwise Reports | February 4, 2020 |

Investment opportunities in America's energy pipeline needs

The Keystone XL ruckus shone a light on pipelines like never before. From the heated nature of the debate one could be forgiven for thinking that long, high-volume pipelines are something new to America. Really, that couldn't be further from the truth: The United States bu...
Marin Katusa | October 28, 2012 |

PDS Biotech Collaborating with Merck in Phase 2 Cancer Trial

This morning PDS Biotechnology Corp. shares are trading 38% higher after reporting that it will enter into a clinical collaboration with Merck pairing the firm's PDS0101 with KEYTRUDA for patients with recurrent or metastatic head and neck cancer and high-risk HPV16 infection....
Streetwise Reports | October 4, 2019 |

U.S. Biopharma's 'Biggest Stock Moving Event' Imminent

With study results from this company due out shortly, an analysis of the possible outcomes was provided in a ROTH Capital Partners report. In a May 17 research note, ROTH Capital Partners analyst Yasmeen Rahimi reviewed possible data readout scenarios of En...
Streetwise Reports | May 27, 2019 |

Interim Results Put Biopharma with Tenbagger Potential 'Back on the Map'

A key upcoming catalyst and the impact of recent positive trial results are addressed in a ROTH Capital Partners report. In a June 5 research note, ROTH Capital Partners analyst Yasmeen Rahimi explained how recent results from Allena Pharmaceuticals Inc...
Streetwise Reports | June 12, 2019 |

US Dollar Rallies Off Support But Is This A Top Or Bottom?

The US dollar rally nearly half a percent today off recent support near $96.50. This upside price move confirms the capital shift we have been talking about. Foreign capital is pouring into US markets and US dollar as strength in the US economy continues to dominate. This ...
Chris Vermeulen | June 19, 2019 |
1 2 3 4 5 6 7